Tag Archives: AstraZeneda

AZ's Seroquel Battle with FDA: A Mark of Desperation?

By Ana Nicholls, Healthcare Analyst at the Economist Intelligence Unit. Is it a mark of desperation? UK-based pharma company AstraZeneca has resorted to suing the US Food and Drug Administration in a bid to stop it from approving generic competition to Seroquel, the company’s blockbuster anti-depressant, before December 2012.¬†The core patent for Seroquel IR¬†expired in […]
Posted in Guest Blog | Also tagged , , | 3 Comments
  • Categories

  • Meta